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Abstract
Background: Teneurin-1 is a member of a family of type II transmembrane proteins conserved from C.elegans to
vertebrates. Teneurin expression in vertebrates is best studied in mouse and chicken, where the four members
teneurin-1 to -4 are predominantly expressed in the developing nervous system in area specific patterns. Based on
their distinct, complementary expression a possible function in the establishment of proper connectivity in the
brain was postulated. However, the transcription factors contributing to these distinctive expression patterns are
largely unknown. Emx2 is a homeobox transcription factor, known to be important for area specification in the
developing cortex. A study of Emx2 knock-out mice suggested a role of Emx2 in regulating patterned teneurin
expression.
Results: 5’RACE of human teneurin-1 revealed new alternative untranslated exons that are conserved in mouse
and chicken. Closer analysis of the conserved region around the newly identified transcription start revealed
promoter activity that was induced by EMX2. Mutation of a predicted homeobox binding site decreased the
promoter activity in different reporter assays in vitro and in vivo in electroporated chick embryos. We show direct in
vivo binding of EMX2 to the newly identified promoter element and finally confirm that the endogenous alternate
transcript is specifically upregulated by EMX2.
Conclusions: We found that human teneurin-1 is directly regulated by EMX2 at a newly identified and conserved
promoter region upstream of the published transcription start site, establishing teneurin-1 as the first human EMX2
target gene. We identify and characterize the EMX2 dependent promoter element of human teneurin-1.
Background
Many transmembrane proteins mediate cell-cell interac-
tions and thereby regulate key developmental processes.
Teneurins are a unique family of type II transmembrane
proteins conserved from Drosophila melanogaster and
Caenorhabditis elegans to vertebrates, where four paralo-
gues exist called teneurin 1-4 [1]. This protein class was
discovered in a screen for the Drosophila homologue of
the extracellular matrix protein tenascin-C [2]. Structure
and domain architecture are highly conserved across
phyla. All proteins of the teneurin family share a large
extracellular domain with eight tenascin-type EGF-like
repeats followed by a region of conserved cysteines and
YD repeats [3]. Recently, several publications suggested
that the C-terminal parts of the teneurin proteins contain
peptides with similarities to corticotrophin-releasing factor
( C R F )a n dm i g h th a v eaf u n c t i o ni nm o d u l a t i n gC R F -
mediated behavior [4]. All vertebrate teneurins have an
N-terminal intracellular domain with two polyproline
motifs, EF-hand-like metal ion binding sites and several
putative phosphorylation sites. This intracellular domain
was shown to be cleaved from the membrane and translo-
cates into the nucleus where it can interact with transcrip-
tion factors and alter gene expression [5-7].
In C. elegans, RNAi knockdown and deletion of its sin-
gle teneurin gene (Ten-1) results in a broad range of phe-
notypes, including defects in axon guidance and neuronal
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sion of the vulva [8-10]. Drosophila harbors two teneurin
genes, Ten-a [2] and Ten-m/Odz [11,12]. Mutations in
either of these genes result in embryonic lethality and
Ten-a mutants enhance the segmentation phenotype of
weak alleles of Ten-m/Odz [13]. It was also shown that
teneurin expression is required for the proliferation and
cellular identity in the Drosophila eye [14]. Extensive
localization studies in mouse [15-17] and chicken
[ 5 , 1 8 - 2 0 ]e m b r y o s ,a sw e l la si nr a t[ 2 1 ]a n dz e b r a f i s h
[22] revealed that the different members of the teneurin
protein family are expressed with overlapping patterns by
distinct subpopulations of neurons. Experiments in vitro
and in vivo showed that the different members of the
teneurin family form disulfide-linked dimers [16,23] and
promote homophilic cell-cell adhesions and neurite out-
growth [18,24]. These functions of the protein are
believed to mediate correct pathfinding and area recogni-
tion of neurons. This was shown in the teneurin-3 knock-
down mouse, which exhibits dramatic changes in the
mapping of ipsilateral retinal inputs causing mismatches
in binocular mapping. This is associated with major defi-
cits in the performance of visually mediated behavioral
tasks [25].
Recent findings suggest an important role for the
teneurin protein family in establishing cortical arealiza-
tion and patterning in the developing embryo. Teneurin-
2 was found to be expressed in developing limbs, somites
and craniofacial mesenchyme in a pattern strikingly simi-
lar to that of fibroblast growth factor 8 (Fgf8) and Fgf8
coated beads implanted into chicken limb buds induced
ectopic teneurin-2 expression in situ [20]. Furthermore,
teneurin-4 transcripts are down regulated, and the
expression patterns of teneurins are shifted in the cor-
tices of mice deficient in Emx2 [26]. These findings link
the regulation of teneurin expression to Fgf8 and Emx2,
two proteins that are part of a complex network of
growth and transcription factors regulating arealization
of the developing brain, a crucial event regulating sensory
perception, the control of our movements and behavior
(reviewed in [27]). The best studied protein in this net-
work is Emx2. Emx2 is the vertebrate homologue of the
Drosophila empty spiracles (ems) protein, which is
involved in the development of the fly head [28]. This
protein is a homeobox-containing transcription factor
implicated in mouse cerebral cortex development [29]. It
is expressed in a graded manner from rostral (low) to
caudal (high) [30-33]. Knock-out and overexpression stu-
dies of Emx2 showed the function of this transcription
factor in establishing the correct size and positioning of
cortical areas [reviewed in 34]. Comparing expression
analyses of different embryonic stages to the adult for
both Emx2 [32,33] and teneurins [5,7,35] showed that
areas of Emx2 expression (e.g., the cortical plate, dentate
gyrus and the olfactory bulb) strongly correlate with
areas of teneurin expression, suggesting a possible role of
teneurins in mediating arealization.
The human teneurin-1 gene resides on the × chromo-
some at position Xq25, a locus with low gene density
[reviewed in 36]. Beside severe mental retardation,
patients suffering from a syndrome mapped to this locus
also suffer from motor sensory neuropathy, deafness and
severely impaired vision [37-41]. Given the predominant
expression in the developing brain and its function in
establishing proper connectivity in the brain, teneurin-1
is a potential target gene for causing XLMR.
In order to provide the basis for an investigation of
possible deletions and mutations in teneurin-1 of XLMR
patients, we decided to delineate the gene locus and
determined the transcription start site(s) of human
teneurin-1. We identified a novel promoter upstream of
the published transcription start, which is conserved in
chicken and mice. We show that EMX2 directly binds to
and regulates human teneurin-1 expression at this alter-
nate promoter.
Results
Identification of alternate transcription start sites of the
teneurin-1 gene
Whereas the expression and localization of the different
members of the teneurin protein family are well charac-
terized, promoter regions regulating teneurin gene
expression in vertebrates have not yet been studied. To
find the transcription start point of human, mouse and
chicken teneurin-1 (gene name is ODZ1), we performed
5’-RACE on brain cDNAs of the respective species. We
used gene-specific primers derived from the first coding
exon and in each case identified two classes of products
(Figure 1 and Table 1). The first class ended with the
5’UTR of the published first exon containing the transla-
tion start site (as depicted in the genome browser as
ODZ1), and the second class included additional non-
coding exons. Two additional exons were found in
human, three in mouse, and one in chicken teneurin-1.
All of these exons were between 80 kb and over 200 kb
d i s t a n tf r o mt h ef i r s tc o d i n ge x o n .C p Gi s l a n d sw e r e
found surrounding the newly identified alternate first
exon suggesting promoter activity in this region. Using
4 kb of sequence surrounding the newly identified first
exon of human teneurin-1 to BLAST the mouse genome
revealed that this entire region was conserved between
species with an overall sequence identity of 58%, and
included local sequence identities of over 90%. Based on
these findings, we considered that teneurin-1 expression
is regulated by two different promoters that are used to
differentially regulate teneurin-1 expression.
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constructs in cell culture
To test whether human teneurin-1 is a direct target gene
of EMX2, we set up a reporter gene assay. We obtained a
myc-flag-tagged EMX2 expression plasmid to transfect
NIH3T3 cells. Recombinant EMX2 could be detected in
cell extracts as a 37kD protein band on Western blots
with a FLAG antibody (Figure 2a) and the protein accu-
mulated in the nuclei of the cells as shown by immunos-
taining (Figure 2b). In order to do promoter reporter
assays, we cloned a 4 kb fragment of highly conserved
genomic sequence around the published transcription
start site, as well as around the newly determined
upstream transcription start site of human teneurin-1
into a pSEAP2-basic reporter vector. These promoter
reporter constructs were co-transfected with the EMX2
plasmid into HEK293 cells and reporter gene activity was
measured (Figure 2c). Interestingly, EMX2 was able to
strongly induce reporter gene activity from the newly
identified upstream promoter 2, but not from promoter
1, which remained unchanged compared to the empty
vector control. Previously it was shown that EMX2 binds
to a homeobox binding motif in the Wnt-1 promoter
[42]. Upon sequence analysis of the promoter 2 construct
we found one conserved site with a high score for EMX2
binding, while the promoter 1 construct possessed sev-
eral high scoring binding sites. This indicates that the
mere presence of core sequences of homeobox binding
elements is not sufficient per se for the induction by
EMX2, but the context may matter as well. To examine
whether the homeobox binding motif in the promoter 2
construct contributes to the reporter gene activation
upon EMX2 co-transfection, we mutated this motif and
measured secreted embryonic alkaline phosphatase
(SEAP) reporter gene activity. Indeed, the SEAP activity
dropped significantly to 50% compared to the wild-type
construct (Figure 2c).
EMX2 transactivates a teneurin-1 promoter construct in
chick embryos electroporated in ovo
To further prove the promoter activity of the upstream
sequence, as well as its dependence on EMX2 expres-
sion, we carried out an in ovo reporter gene assay in
chick embryos. Upon co-electroporation of the promo-
ter 2-lacZ construct with the EMX2 expression vector
in the chick embryo neural tube, lacZ staining was
strongly detected in the electroporated area (Figure 3b),
whereas no staining was visible with the empty lacZ vec-
tor control (data not shown) or upon electroporation
with the promoter 2-lacZ construct alone (Figure 3b). A
GFP-expressing construct was always co-electroporated
as well and used as a control for the efficiency of elec-
troporation (Figure 3a).
To confirm the influence of the putative EMX2 binding
motif on reporter gene activation in vivo, we co-electro-
porated the mutant promoter 2-lacZ construct with
EMX2 and compared the staining with that of embryos
co-electroporated with the wild-type promoter 2-lacZ
construct and EMX2. Similar to the cell culture based
reporter gene assay (Figure 2), reporter gene activity was
also strongly reduced in vivo. Indeed, the vast majority of
the embryos co-electroporated with EMX2 and the
mutated promoter 2-lacZ construct showed a much
fainter lacZ staining than those co-electroporated with
Figure 1 Determination of teneurin-1 transcription start sites. BLAT alignments to the corresponding RefSeq sequences of 2 representative
clones per species obtained by 5’ rapid amplification of cDNA ends are shown. The sequences of the clones are given in Table 1. The human
clone h1_cl_1, the mouse clone m1_cl_1 and the chicken clone c1_cl_1 start with the annotated first exon containing the ATG translation start,
whereas clones h1_cl_2, m1_cl_2 and c1_cl_2 contain up to three further non-coding exons. Based on the presence of two different
transcription start sites, two alternate promoters (grey shaded areas) are postulated to control the expression of the two types of transcripts.
Promoter 1 resides upstream of the first coding exon, whereas Promoter 2 is located about 100-200 kb upstream depending on the species
analyzed.
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ure 3b). These findings show that EMX2 is able to induce
reporter gene activity at the alternate teneurin-1 promo-
ter and that this activation is greatly dependent on an
intact homeobox binding motif.
EMX2 binds a homeobox core element in the alternate
teneurin-1 promoter
To prove that the activation of the construct is due to the
direct binding of EMX2 to the homeobox binding motif
in the novel upstream promoter, we performed an elec-
trophoretic mobility shift assay (EMSA). Nuclear extracts
of HEK293 cells transfected with the EMX2 construct
showed a shift of the labeled probe containing the puta-
tive homeobox binding site of the upstream promoter,
whereas no shift was observed in nuclear extracts of
untransfected HEK293 cells or with a mutated labeled
probe (Figure 4a, lanes 1-3). To show the specificity of
the binding, the effect of wild-type or mutated unlabeled
oligo-nucleotide on the protein/DNA interaction was
analyzed. Whereas no shift of the oligo-probe was visible
when competing with the unlabeled wildtype oligo-
nucleotide, the shift was still detected in the presence of
excess mutant unlabeled oligo-nucleotide (compare lanes
4 and 5). The complex was super-shifted with a c-myc
antibody against the tagged EMX2, and indeed the
shifted band disappeared (lane 6). This indicates a direct
binding of EMX2 to the probe, but due to a high unspeci-
fic background the super-shifted band could not be
resolved.
Table 1 Sequences obtained in 5’RACE (Translation start site in bold and underlined)
clone name sequence
h1_cl_1 TTTTTTTTTTTTTTTGAACTGAGCTTGCTTAATCAGAGATGGAGCAAACTGACTGCAAACCCTACCA
GCCTCTACCAAAAGTCAAGCATGAAATGGATCTAGCTTACACCAGTTCTTCTGATGAGAGTGAAG
ATGGAAGAAAACCAAGACAGTCATACAACTCCAGGGAGACCCTGCACGAGTATAACCAGGAGCT
GAGGATGAATTACAATAGCCAGAGTAGAAAGAGGAAAGAAGTAGAAAAATCTACTCAAGAGAT
GGAATTCTGTGAAACCTCTCACACTCTGTGCTCTGGCTACCAAACAGACATGCACAGCGTTTCTCG
GCATGGCTACCATCTAGA
h1_cl_2 TTTTTTTTTTTTTTTTGGCGGGGGANCAGCACCTGGGGACGCCGCCGAAACTTGCGCTTGGAATA
GGAATTACAAGGGTGACCTTTATTCCGCTGTCTCCTTTTTGATTCCCATAACTTCTGGACCTATCAA
GGACTGCTTGCATTAAAGGACTTCCTCATCCTTTTTTTCATGAAACTGAGCTTGCTTAATCAGAGA
TGGAGCAAACTGACTGCAAACCCTACCAGCCTCTACCAAAAGTCAAGCATGAAATGGATCTAGCT
TACACCAGTTCTTCTGATGAGAGTGAAGATGGAAGAAAACCAAGACAGTCATACAACTCCAGGG
AGACCCTGCACGAGTATAACCAGGAGCTGAGGATGAATTACAATAGCCAGAGTAGAAAGAGGA
AAGAAGTAGAAAAATCTACTCAAGAGATGGAATTCTGTGAAACCTCTCACACTCTGTGCTCTGGC
TACCAAACAGACATGCACAGCGTTTCTCGGCATGGCTACCATCTAGA
m1_cl_1 TTTTTTCCACCGCCACCTCCTCCACATGCCTGCACCTGTGCCAGGAAGCCACCTCCTACAGTGGAC
TCTCTACAAAGAAGATCAATGACTACCCGCAGCCAGCCCAGCCCAGCTGCTCCTGCTCCTCCAACC
AGCACACAGGATTCGGTTCATCTGCATAACAGCTGGGTCTTGAACAGTAACATACCGCTGGAGAC
CAGGTACATTTTATGATTGACCATTTCAGCAAAGACTGTTTTCATTAAAGAACTTCCTTATCCTTTT
TTCATGAAACTCAGCTTGCTTAATCAGAGATGGAGCAAACAGACTGCAAACCTTATCAGCCTCTG
TCCAAAGTCAAGCATGTCTAGA
m1_cl_2 TTTTTTCCCGCAGGAACCAGCAAAGACGCCCTAAGTCCAGCGCACTTACAGCACACCAGCAGAGC
TGAGTACCTGGCAAGGAGGCGGGGGACCGCACCTGAGGACATCACTGAAACTTGCGCCTGGACT
AGTCCTTCTACTGCCATGGAAACTAGATGGCACAGACAGCGGAGAGTCACTCATTCAGAACAGG
GGCCCCCTTTTTAATTTCATGTCAGCCTGTTGGTCCCTGAAAGTAACTGAAAAGGAATTACAAGA
GCGACTTTTATTCTGTGTAACTTCTCTTCTGGATCTAACAAGGTACATTTTATGATTGACCATTTCA
GCAAAGACTGTTTTCATTAAAGAACTTCCTTATCCTTTTTTCATGAAACTCAGCTTGCTTAATCAGA
GATGGAGCAAACAGACTGCAAACCTTATCAGCCTCTGTCCAAAGTCAAGCATGTCTAGA
c1_cl_1 TTTTTTTCCTCATTCCTTAAGGAATTCCAGTTGCTTGTTTTCATGATTTTGAGCCTATTCAGCCAGA
GATGGAGCAGATGGACTGCAAACCCTACCAGCCACTGTCAAAAGTTAAACATGAAGTGGATCTA
ACNTTACACAAGTTCTTCAGATGAAAGTGAAGATGGCAGAAAGCAAAGGCAATCTTATGACTCA
AGAGAAACTCTGAATGAATATAGCCAAGAGCTAAGACTGAACTACAACAGTCAAGGCAGAAAAA
GAAAAAATACTGACCAATCCACACAAGACATGGAATTCTGTGAGACACCCCACATTCTGTGCTCT
GGCTACCAAACAGATTTACATGGTGTGTCGGAGCACAGCTACCCACTAGAGGTGGGCTCAGATG
TTGATACTGAAACCGAAGGTGGCGCATCACCAGATCATGCCCTGAGGATGTGGATGAGGGGGAT
GAAGTCAGAACACAGCTCCTGTCCGTCAAGCCGGGCAAACTCAGCGTTGTCCCTGACTGACACTG
ACCATGAGAGGAAGTCTGATGGGGAGAATGACATGCCGGGGAGCCCACACAACCAGTTCACGTT
TCTAGA
c1_cl_2 TTTTTTTCGCCGAGCCTAGAGGCGATGGGAGCTGCCGAGCCGGGGCGCTGCTGAAAGTTCAGCC
GGTGGCCGCGCAGCGCGGACTCATCCTTAAGGAATTCCAGTTGCTTGTTTTCATGATTTTGAGCC
CATTCAGCCAGAGATGGAGCAGATGGACTGCAAACCCTACCAGCCACTGTCAAAAGTTAAACAT
GAAGTGGATCTAACTTACACAAGTTCTTCAGATGAAAGTGAAGATGGCAGAAAGCAAAGGCAAT
CTTATGACTCAAGAGAAACTCTGAATGAATATAGCCAAGAGCTAAGACTGAACTACAACAGTCAA
AGCAGAAAAAGAAAAAATACTGACCAATCCACACAAGACATGGAATTCTGTGAGACACCCCACA
TTCTGTGCTCTGGCTACCAAACAGATTTACATGGTGTGTCGGAGCACAGATACTCTAGA
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the nuclear extract, we tested EMX2 produced by
in vitro transcription and translation in the gel shift
assay. Whereas no shift of the labeled probe was
detected with mock extracts, the same shifted band as
with the nuclear extract could be detected with in vitro
transcribed and translated EMX2 (Figure 4b, lanes 1 and
2), while unspecific background was greatly reduced.
The binding of the protein to the probe was successfully
competed with an excess of unlabeled wildtype oligo-
nucleotides (Figure 4b, lane 3), whereas no competition
was detected for unlabeled mutated oligo-nucleotides
(Figure 4b, lane 4). Adding c-myc antibody to the bind-
ing reaction resulted in a super-shifted band (Figure 4b,
lane 5), indicating a direct binding of EMX2 to the
homeobox motif in the alternate teneurin-1 promoter.
To test whether an interaction between EMX2 and the
binding site in the teneurin-1 promoter can also occur in
vivo without overexpression of the EMX2 protein, we
tested nuclear extracts of brains from E12.5 embryos
known to express high EMX2 levels in the EMSA assay
( F i g u r e4 c ) .W ew e r ea b l et od e t e c tas h i f to ft h eb a n d
with the embryo extract, which runs lower than the com-
plex of the overexpressed tagged protein in the control
(compare Figure 4c, lanes 1, 2). We were able to compete
the binding to the probe with wildtype unlabeled oligo-
nucleotides, whereas no competition was detected using
the unlabeled mutated oligo-nucleotide (Figure 4c, lanes
3-4). As a final proof of direct binding of EMX2 to the
endogenous teneurin-1 promoter at the homeobox bind-
ing site in vivo, we performed chromatin immunoprecipi-
tation (ChIP) in chicken embryos electroporated with the
FLAG-myc-tagged EMX2 construct. Electroporations
were performed in developing telencephalic regions in
order to test the ability of Flag-myc-tagged EMX2 to
bind the target region in its physiological cell context.
Indeed, we detected specific enrichment of the target
region containing the homeobox binding site after ChIP
with the anti-FLAG antibody, recognizing the electropo-
rated tagged EMX2 protein compared to a negative con-
trol region, which was not the case in control embryos
(Figure 4d).
Teneurin-1 expression pattern correlates with that of
EMX2 in E14.5 embryos
To test whether the endogenous teneurin-1 expression
pattern overlaps with sites of EMX2 expression in the
developing brain, we performed in situ hybridizations with
a probe for EMX2, a probe for total teneurin-1 and an
additional probe specific for the alternate transcript of
teneurin-1 on adjacent sagittal brain sections (Figure 5).
The staining for teneurin-1 transcripts showed expression
at sites that are in accordance with those reported before
for E15.5 embryos [26]. Interestingly, staining with a probe
specific for the alternate transcript revealed the same
staining pattern as the probe for total teneurin-1, indicat-
ing that the long transcripts are indeed expressed at these
stages of embryogenesis. We detected a correlation
Figure 2 Transcriptional activation of teneurin-1 promoter reporter constructs by EMX2. (A) NIH3T3 cells were transfected with a flag-
myc-tagged EMX2 construct or an empty vector and tested for expression by Western blot of whole cell extract with anti-Flag. (B)
Immunostaining of the cells with anti-Flag reveals the nuclear accumulation of the EMX2 protein in the nuclei of the cells. (C) HEK293 cells were
transfected with EMX2 or empty vector control and co-transfected with different promotor constructs as indicated. The graph shows relative
SEAP values for one representative experiment performed in triplicates (n = 5). The activity obtained with the Promotor 1 construct is arbitrarily
set to 1. Error bars display standard deviation of the mean. The sequences of the region harboring the putative binding site and the mutation
used (mut Promoter 2) are shown in the box above the bar graph.
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caudal high to rostral low gradient. We find teneurin-1
being expressed in the marginal, but not in the ventricular
zone of the cortex. Especially good correlations were
found in the caudal cortex, olfactory bulb (ob) and hippo-
campus (hi) (Figure 5).
EMX2 specifically induces the transcription of the
alternate transcript
To test whether EMX2 is able to induce the endogenous
teneurin-1 gene from the alternate promoter, we set up a
real-time Q-PCR assay. We compared the mRNA expres-
sion level for total teneurin-1, as well as for the presence
of the exons specific for the alternate transcript in paren-
tal HEK293-ECR cells with HEK293-ECR cells stably
expressing myc-flag-tagged EMX2 (Figure 6). Indeed, the
EMX2 expressing cells showed significantly (p < 0.01)
elevated transcript levels of total teneurin-1. Although we
generally observed a low expression level for the alternate
transcript in our cells, it showed a much higher fold
i n d u c t i o nu p o nE M X 2e x p r e s s i o nt h a nt h et o t a lm R N A .
This is further support for our reporter gene studies on
the level of the endogenous gene and represents an inde-
pendent confirmation that EMX2 specifically acts on the
alternate promoter of teneurin-1.
Discussion
In this work, we characterized the teneurin-1 gene locus
and found novel upstream exons which are conserved
between species. These new exons expand the size of the
Odz1 locus to more than 800 kb, harboring one intron
which is more than 200 kb in size. Genes with large
introns have been reported before [43]. A continuous
transcription of the entire gene, given a polymerization
rate of 3800 nucleotides per minute by RNA polymerase
II, would take 3.5 h [44]. This might add another level of
regulation of the defined expression in time and space.
Here we show that there are at least two promoters regu-
lating teneurin-1 expression with one alternate promoter
upstream of the published transcription start. Only this
alternate promoter was inducible by EMX2 in reporter
gene assays and cells stably overexpressing EMX2 exhib-
ited an increase of the resulting alternate transcript. A
single homeobox binding site seems to be critical for the
Figure 3 C h i c k e nE m b r y oE l e c t r o p o r a t i o n .( A )E m b r y o sw e r e
electroporated at Hamburger and Hamilton stage 10 and collected
24 h later. A CMV-GFP plasmid was always used as positive control
of the electroporation and only embryos showing an expression
pattern as shown were kept. Embryos electroporated with beta-
globin_LacZ (BGZ40) plasmid alone or in combination with EMX2 in
pCMV6-Entry (CMV-EMX2) were used as negative controls (not
shown). (B) A 4 kb genomic fragment of the teneurin-1 promoter
was cloned into the reporter plasmid beta-globin-LacZ (ten-1BGZ40)
and electroporated alone (WT control) or in combination with CMV-
EMX2 plasmid (WT + EMX2). A mutated version of ten-1BGZ40
lacking a potential EMX2 binding site (mut ten-1BGZ40) was
electroporated alone (data not shown) or in combination with CMV-
EMX2 (Mut + EMX2). (C) Electroporation results are summarized in
stacked columns. Data are represented as percentile of the total
number of electroporated embryos (n = 16 for the WT construct
and n = 26 for the mutated construct) and are classified according
to three levels of reporter expression: strong staining, medium
staining and no or weak staining.
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Page 6 of 12Figure 4 Direct binding of EMX2 to teneurin-1 promoter oligo-nucleotide probes. (A) Electrophoretic Mobility Shift Assays (EMSA) using
EMX2 containing nuclear extract or control nuclear extract were performed in the presence or absence of Dig-labeled probe, unlabeled probe
for competition, mutated probes and anti-myc antibody as indicated above the lanes. A specific myc-EMX2/DNA complex could be detected as
indicated by an arrow. (B) EMSA with in vitro transcribed and translated EMX2 protein or control extracts were analyzed using Dig-labeled
wildtype and mutated probes as indicated. Binding to the probe resulted in a myc-EMX2/DNA complex as indicated by an arrow that was
competed by unlabeled probe and resulted in a supershifted complex after addition of anti-myc-antibody as indicated. (C) EMSAs with nuclear
extracts of E12.5 embryos and nuclear extract of myc-EMX2 overexpressing cells as a control were performed using Dig-labeled wildtype probe.
Binding to the probe resulting in a myc-EMX2/DNA complex and an EMX2/DNA complex is indicated by arrows. (D) ChIP of chicken embryos
electroporated with flag-myc-tagged EMX2 (+) and control chicken embryos (-). Fold enrichment of the target region, containing the homeobox
binding site versus a negative control region from the coding region of the same gene after anti-flag precipitation is shown. Error bars display
standard deviation of the mean.
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Page 7 of 12promoter activity and is bound directly by EMX2, as
shown by gel shift assay and ChIP in chicken embryos.
Although one has to take into account that the teneurin-
1 expression, especially in later developmental stages,
opposes the expression pattern of EMX2, a direct regula-
tion of teneurin-1 expression by EMX2 is likely to occur
at earlier stages. First, we and others [26] showed that
total teneurin-1 expression, as well as the expression of
the alternate transcript, correlates well with EMX2
expression at E14.5. Secondly, the expression of teneurin-
1 is highly dynamic and its patterned expression and the
overall expression level collapses in EMX2-deficient mice
[26]. Notably, we found teneurin-1 being expressed in
the marginal, but not in the ventricular zone of the cor-
tex. This suggests a possible function of EMX2 in post-
mitotic neurons via the control of teneurin-1. Based on
these findings, it is conceivable that the promoter at the
published transcription start is responsible for the basal
expression of teneurin-1, whereas the novel promoter is
responsible for the graded expression dependent on
EMX2. This finding suggests that this promoter region of
the teneurin-1 gene is essential in establishing correct
patterning of teneurin-1 expression. Although the tran-
scription factors involved in correct patterning and area-
lization are well known, and their expression patterns are
well characterized, very little is known about the down-
stream mechanisms contributing in establishing proper
arealization and pathfinding [reviewed in 45]. A number
of reports describe screens to find genes which are differ-
entially expressed within the cortex [24,46,47] or which
are potential target genes of differentially expressed tran-
scription factors [11,26,48-50]. Interestingly, in both
types of approaches members of the teneurin protein
family were revealed as differentially expressed genes,
supporting the evidence for a role of teneurin in arealiza-
tion. Lists of potential target genes of the transcription
factors involved in arealization, like Emx2 or Pax6, have
also been described in knock-out gene expression studies
[26,31,48], but indirect effects on transcription cannot be
ruled out and interesting targets need to be validated. In
this study, we validated teneurin-1 as the first direct tar-
get gene of EMX2 in human. As a transmembrane pro-
tein, teneurin-1 is well-suited to convey nuclear signals
to the level of cell-cell interactions. However, the mole-
cular mechanisms of how teneurins mediate their pro-
posed function in brain development and patterning of
the cortex remain to be elucidated.
Many cases of XLMR have been mapped to Xq25, the
locus of the teneurin-1 gene [37-41]. Interestingly, many
of these individuals suffer from motor sensory neuropathy
[37], and teneurin-1 is predominantly expressed in
patterns that relate to anterior sensorimotor areas [26].
Taking into account the regulation of teneurin-1 by
EMX2 at the novel promoter, setting up proper arealiza-
tion of the developing cortex, and the well established
functions of teneurins in correct pathfinding and neurite
growth, we consider teneurin-1 as a potential target gene
for XLMR. When analyzing patient samples, attention
should be given to the newly established promoter region,
as mutations or deletions in this area could lead to a shift
in expression of teneurin-1 early in the developing brain
Figure 5 In-situ hybridizations for Teneurin-1 and EMX2
expression on sagittal sections at E14.5 mouse embryos. (A; A’)
Expression of EMX2 in the cortex at higher magnification in A’. (B;
B’) Expression of total teneurin-1 in an adjacent section. (C; C’)
Expression of the alternate transcript of teneurin-1 in an adjacent
section. Ob, olfactory bulb; hi, hippocampus
Figure 6 Activation of the alternate transcript by EMX2.R N A
was isolated from parental HEK293 cells (-) and HEK293 cells stably
expressing EMX2 (+). Teneurin-1 mRNA levels of 3 independent
preparations were measured by real-time PCR. The graph shows
total teneurin-1 mRNA (total ten1) and mRNA levels under control
of the alternate promoter (alternate transcript) relative to GAPDH
mRNA values. Values of the parental cells were arbitrarily set to 1.
Error bars display standard error of the mean.
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XLMR.
Conclusion
In this work, we show that teneurin-1 expression is
r e g u l a t e db yE M X 2a tan o v e la n dc o n s e r v e du p s t r e a m
promoter. We present teneurin-1 as the first direct tar-
get gene in humans and characterize the binding site in
the newly identified promoter region.
Methods
Rapid amplification of 5’ complementary DNA ends (5’
RACE)
Total RNA of mouse and chicken brain tissue was purified
with QiaShredder and RNA Easy kit (Qiagen, Hombrechti-
kon, CH) according to manufacturer’s instructions. Using
these RNA extracts and total human adult normal brain
RNA (ams Biotechnology, Oxon, UK) 5’RACEs were per-
formed with the 2nd generation 5’/3’RACE kit (Roche
Diagnostic, Mannheim, Germany) according to manufac-
turer’s instructions. Nested PCRs with the primer
sequences shown in Table 2 were performed. The bands
obtained were purified and cloned into vector pKS
+ and
sequenced. The sequences were analyzed using the BLAT
algorithm on human genome assembly GRCh37, mouse
assembly July 2007 and chicken assembly May 2006
(http://genome.ucsc.edu) [51].
Promoter studies
The promoter constructs for human teneurin 1 were
amplified from human genomic DNA using the Expand
High Fidelity system (Roche) with primer hten1 promoter
1 XhoI fw (all primer sequences are given in Table 2) and
hten1 promoter 1 HindIII rev using the highlighted
restriction sites for directional cloning into vector
pSEAP2-Basic (Clontech, Mountain View, CA, USA) of
the promoter 1 construct. For the hten1 promoter 2 con-
struct, we used hten1 promoter 2 NheI fw and hten1 pro-
moter 2 EcoRI rev using the highlighted restriction sites
for directional cloning into the same vector. The promoter
1 construct contains a sequence of just over 2 kb from
nt124097602 to nt124099666 of chromosome × and the
promoter 2 construct around 4 kb from nt124336306 to
nt124340205 on chromosome × of assembly GRCh37.
Analysis of the promoter sequences for potential binding
sites was done using the JASPAR database (http://jaspar.
cgb.ki.se[52]) and the ems matrix. Mutation of the poten-
tial homeobox-binding sequence (nt124338584 to
nt124338589 on chromosome X) in the promoter 2 was
achieved using overlapping PCR with the primer set for
hten1 promoter2 and mutated promoter 2 fw and rev.
HEK293-EBNA cells were plated at 1 × 10
5 cells per well
in six-well plates 18 h before transfection. Cells were
transfected in DMEM containing 0.3% FCS with Fugene 6
Transfection reagent (Roche) using 1 μg promoter con-
struct DNA and co-transfected with either empty 1 μg
pcDNA3 or flag- and myc-tagged EMX2 in pCMV-Entry
(OriGene, Rockville, MD, USA) as indicated in the Result
section. Twenty-Four hours after transfection, the medium
was collected and SEAP reporter gene activity was mea-
sured and normalized for the co-transfected plasmid
pGL3, expressing firefly luciferase (Promega, Madison,
WI, USA) as previously described [53].
Real-time Q-PCR
HEK293-ECR cells were transfected as described before
with the flag-myc-tagged EMX2 construct in pCMV and
cells were selected for stably expressing clones with
G418 (Roche) for 2 weeks. Clones were pooled and
expression of the construct was tested by Western blot
Table 2 Primer sequences
Primer name Sequence
human RT-PCR TTAGTGCATGGTCAGGTGAGG
mouse RT-PCR TCTCCCATCTTCACTCTCATCAG
chicken RT-PCR GCTGTGTTCTGACTTCATCC
hten PCR1 rev GTGTCCACATCAGATCCCATCTC
hten nested XbaI rev TAGTTCTAGAGCACAGGTGCAGGCATGAGG
mouse PCR1 rev CTCCAGCTGGTAGCCATGTCG
mouse nested XbaI
rev
TAGTTCTAGATCTGTGTGGTAGCCGGAGCAC
chicken PCR1 rev ATGCGCCACCTTCGGTTTCAG
chicken nested XbaI
rev
TAGTTCTAGAGTAGCTGTGCTCCGACACACC
oligo dT anchor
primer
GACCACGCGTATCGATGTCGACTTTTTTTTTTTTTTTT
hten1 promotor 1
XhoI fw
ACTACTCGAGCAAGACCCATGCTGAAGCT
hten1 promotor 1
HindIII rev
ACTAAAGCTTCTCTGATTAAGCAAGCTCAGTTTC
hten1 promoter 2
NheI fw
ACTAGCTAGCCCCCTAGAGTGTTCAGCTCT
hten1 promoter 2
EcoRI rev
ACTAGAATTCGGGCCACCTCAAAAACACCTCC
mutate promoter 2
fw
CCACCCCTCACCCTCAGGAGAAAGTGGTTAAA
mutate promoter 2
rev
TTTAACCACTTTCTCCTGAGGGTGAGGGGTGG
total ten1 qPCR fw GCATAGTTCCTGTTTGTCCA
total ten1 qPCR rev TCTGCACATCTTGAGTAGAC
alt exon qPCR fw GCTTGGAATAGGAATTACAAGG
alt exon qPCR rev GAAGTCCTTTAATGCAAGCAG
hGAPDH qPCR fw GGAGTCAACGGATTTGGTC
hGAPDH qPCR rev AAACCATGTAGTTGAGGTC
ChIP target region fw TTCAGCTTCCTCGTTCTTCG
ChIP target region rev GGTGGTTACAACCGCCTTTT
ChIP negative control
fw
AGATTCCTGTGAGCCCTGCT
ChIP negative control
rev
TCCAACAACTCATGCAATGG
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HEK293-ECR cells RNA was isolated with QiaShredder
and the RNA Easy kit (Qiagen) following the manufac-
turer’s protocol. From this preparation, cDNA was gen-
erated using the Superscript III (Invitrogen) polymerase
and random primers following the standard protocol.
Real-time Q-PCR was performed on these samples with
teneurin-1 specific primers and normalized to GAPDH
values (sequences Table 2) using SYBR QPCR Supermix
with ROX (Invitrogen) on an AbiPrism 7000 system.
Three independent experiments were performed and the
averaged results are shown and p-values were calculated
using the one-way ANOVA.
In ovo electroporation
For reporter assay experiments, chicken eggs were incu-
bated in a humidified chamber at 38°gC and DNA con-
structs were injected into the lumen of the neural tube
of stage Hamburger Hamilton (HH) 10-12 embryos.
Construct concentrations were: 1 μg/μll a c Zr e p o r t e r
construct (BGZ40; [54]), 1 μg/μl EMX2 expression vec-
tor, and 0.2 μg/μl co-injected EGFP in pCMV as positive
control of electroporated cells. Embryos were harvested
24 hours after electroporation and processed for
b-galactosidase staining. For EMX2 overexpression,
1 μg/μl of Myc/FLAG-tagged EMX2 expression vector
and 0.2 μg/μl of pCMV-EGFP construct were co-
injected into the lumen of forebrain of stage HH 14
embryos. Positive tissues (n = 20 brains) were collected
72 hours after electoporation and immediately processed
for chromatin cross-linking. As negative control, the
same amount of unelectroporated tissue was collected
and processed for ChIP experiments. Electroporations
were performed as described previously using a square
wave electroporator [54].
Chromatin immunoprecipitation Assay
Brains were chopped and then cross-linked in 1% For-
maldehyde (F8775, Sigma) for 10 minutes at room tem-
perature. Cross-linking was stopped in 125 mM Glycine
for 5 minutes and the material was washed three times
in ice cold PBS containing EDTA-free Protease Inhibitor
Cocktail (Complete, 04693132001, Roche). DNA shear-
ing was performed in lysis buffer (50 mMTris-HCl
pH8.0, 10 mM EDTA, 1%SDS, 1 × Protease Inhibitor
Cocktail) using the following parameters: 20 cycles of 30
seconds ON/30 seconds OFF (Diagenode bioruptor
sonicator, high power setting).
Chromatin immunoprecipitation was performed by
using Dynabeads protein G (100.04D, Invitrogen) as
described elsewhere [55]. The following antibodies were
used: Mouse monoclonal anti-FLAG M2 (F1804, Sigma),
Mouse control IgG (AB18413, Abcam).
Electrophoretic Mobility Gel Shift Assay (EMSA)
EMX2 binding to the promoter construct was examined
by Electrophoretic Mobility Gel Shift Assay (EMSA)
using DIG-labeled double-stranded oligo-nucleotides
(5’CAGGAGAAAGTAATTAAAAAA3’ or with mutated
binding site 5’CAGGAGAAAGTGGTTAAAAAA3’,
putative binding site underlined). For probe preparation,
5 μg of sense and anti-sense oligo-nucleotides were
diluted in 90 μl TE buffer, incubated for 10 min at 95°C
and cooled down for 30 min at room temperature for
annealing. DIG-labeling of the probes was achieved
using the DIG Gel Shift Kit, 2
nd Generation (Roche)
according to the manufacturer’s instructions. For the gel
shift assay, nuclear extracts from stably EMX2 expres-
sing HEK293 cells, in-vitro translated extracts or nuclear
extracts of E12.5 embryo brains containing 20 μgo f
total protein were incubated with 4 μlo f5×b i n d i n g
buffer of the Gel Shift Kit, 1 μgd o u b l e - s t r a n d e dp o l y
(dIdC) and 0.1 μg poly-L-lysine in a 19 μl reaction mix.
For the competition assay, unlabeled wild-type or
mutant annealed oligo-nucleotide were added with a
150-fold excess. This mix was incubated for 20 min at
room temperature. Afterwards, 1 μl of labeled probe
was added and the mix was incubated for another
20 min at 30°C. For supershifts, 1 μl of c-myc antibody
(Sigma) was added after 10 min incubation with the
labeled probe. Following another 10 min of incubation,
the reaction mix was loaded onto a precast 6% DNA
retardation gel (Invitrogen, Carlsbad, CA, USA), which
was pre-run in 0.5 × TBE for 20 min at 80 V and 4°C.
The gel was run for 1.5 h at 80 V and 4°C. After separa-
tion, the complexes were blotted on a positively charged
nylon membrane in 0.5 × TBE for 45 min at 280 mA
and DIG detection was performed as described in the
manufacturer’s instructions.
In-vitro transcription and translation of EMX2
In-vitro transcription and translation of EMX2 was
achieved using the TNT
® Coupled Reticulocyte Lysate
System (Promega). 25 μlo fT N T
® rabbit reticulocyte
lysate, 2 μlT N T
® reaction buffer, 1 μlT N T
® T7 RNA
polymerase, 0.5 μl of each Amino Acid mixture without
Leucine and without Methionine and 1 μgo fE M X 2 -
pCMV-Entry were mixed in a 50 μl reaction mix and
i n c u b a t e df o r9 0m i na t3 0 ° C ,q u i c kf r o z e ni nd r yi c e /
ethanol and stored at -80°C until used in EMSA.
In-situ hybridization
In-situ hybridizations on sections were performed as
previously described [56]. The following RNA probes
were used: For EMX2 we used the entire CDS of EMX2
(NM_010132.2), for total teneurin-1 we used the probe
previously published [26] and for the probe specific for
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Page 10 of 12the alternate transcript we used the sequence described
in Table 1 (m1_cl_2) plus the first 100 bp of the CDS of
mouse teneurin-1 (NM_011855.3).
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